From the publishers of JADPRO

Multiple Myeloma Resource Center

Advertisement

Evaluating pre-transplant nutritional indices as predictors of pneumonia and mortality in multiple myeloma patients post-autologous stem cell transplantation

Last Updated: Friday, November 21, 2025

This retrospective study analyzed 286 multiple myeloma patients undergoing autologous stem cell transplantation (ASCT). The goal was to investigate if pre-transplant nutritional indices—Geriatric Nutritional Risk Index, Prognostic Nutritional Index, and Controlling Nutritional Status score—predict post-transplant pneumonia or one-year mortality. Findings revealed no statistically significant association between these indices and either the incidence of pneumonia or one-year survival after ASCT. 

BMC Pulmonary Medicine
Advertisement
News & Literature Highlights

The Lancet

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial

American Journal of Blood Research

Therapy-related B-cell acute lymphoblastic leukemia after treatment for multiple myeloma

Cancer Epidemiology

Occupational pesticide exposure and association of monoclonal gammopathy of undetermined significance in the Western Macroregion of Paraná

Molecular and Cellular Probes

The role of RNA modifications in the pathological mechanisms and therapeutic targeting of multiple myeloma

The FEBS Journal

Understanding and addressing resistance to IMiDs immunomodulatory compounds in multiple myeloma

Transplantation and Cellular Therapy

Trial in progress: QUINTESSENTIAL-2—a phase 3 Study of arlocabtagene autoleucel versus standard of care in adult patients with relapsed and refractory multiple myeloma (RRMM) exposed to lenalidomide

Journal of Translational Medicine

Long-term follow-up results of anti-BCMA CAR-T cell therapy combined with autologous hematopoietic stem cell transplantation in relapsed/refractory multiple myeloma with extramedullary disease

The Asco Post

Off-the-shelf CAR T-cell therapy produces deep, durable responses in heavily pretreated multiple myeloma

Cancer Medicine

Lenalidomide plus dexamethasone as first-line therapy in transplant-ineligible patients with multiple myeloma

BMC Infectious Diseases

Machine learning triumphs in differentiating fungal and bacterial infections

Advertisement
Advertisement